Cubist Systematic Strategies’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.32M Buy
146,406
+105,505
+258% +$926K 0.01% 1813
2025
Q2
$532K Sell
40,901
-292,716
-88% -$4.4M ﹤0.01% 2235
2025
Q1
$8.42M Buy
333,617
+113,589
+52% +$3.38M 0.05% 576
2024
Q4
$7.56M Buy
220,028
+151,358
+220% +$6.83M 0.05% 605
2024
Q3
$3.39M Sell
68,670
-51,197
-43% -$2.62M 0.02% 1089
2024
Q2
$7.21M Buy
119,867
+1,042
+0.9% +$59.5K 0.05% 570
2024
Q1
$6.13M Buy
118,825
+33,516
+39% +$1.65M 0.03% 835
2023
Q4
$3.44M Buy
85,309
+41,452
+95% +$1.22M 0.02% 1104
2023
Q3
$1.22M Sell
43,857
-38,304
-47% -$1.14M 0.01% 1733
2023
Q2
$2.37M Buy
82,161
+70,386
+598% +$1.57M 0.02% 1353
2023
Q1
$196K Buy
11,775
+9,574
+435% +$135K ﹤0.01% 3243
2022
Q4
$27.9K Sell
2,201
-3,510
-61% -$42.7K ﹤0.01% 3968
2022
Q3
$69K Buy
+5,711
New +$78.4K ﹤0.01% 4078

Other funds holding RXST

Cubist Systematic Strategies's RXST Position: Q3 2025 in Review

Cubist Systematic Strategies increased its RxSight (RXST) stake by 258% in Q3 2025, buying an estimated $926K and bringing the position to 146,406 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1813.

Cubist Systematic Strategies first reported a position in RXST in Q3 2022 and has held it in 13 quarters since. The position peaked at $8.42M in Q1 2025. 160 funds tracked by Wall St. Rank hold RXST as of Q3 2025.

  • Cubist Systematic Strategies held 146,406 shares of RxSight worth $1.32M as of Q3 2025.
  • Cubist Systematic Strategies bought 105,505 RxSight shares in Q3 2025, an estimated $926K.
  • RxSight made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1813 holding.
  • Cubist Systematic Strategies first reported a position in RxSight in Q3 2022 and has held it in 13 quarters since.
  • Cubist Systematic Strategies's RxSight position peaked at $8.42M in Q1 2025.
  • 160 funds tracked by Wall St. Rank held RxSight as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.